我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
隶属于 NATIONAL HEALTH SERVICE
相关临床试验
20
1 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
1985
已完成
11
55.0%
尚未招募
1
5.0%
招募中
2
10.0%
暂停
Unknown
3
15.0%
撤回
暂无批准数据
- Aberdeen Royal Infirmary has been designated as the regional CAR-T treatment center for northern Scotland, eliminating the need for patients to travel hundreds of miles to Newcastle for this life-saving therapy. - Nancy Gray, 68, became the first patient to receive CAR-T therapy at the facility in November 2024 and achieved remission by July, demonstrating the treatment's effectiveness for relapsed lymphoma. - The revolutionary cellular immunotherapy reprograms patients' own T-cells to recognize and destroy cancer cells, offering hope for blood cancer patients who haven't responded to conventional treatments like chemotherapy. - Consultant haematologist Gavin Preston described CAR-T as "a massive breakthrough" that establishes Aberdeen Royal Infirmary as a center of excellence in haematology care.